Johnson & Johnson (JNJ) Tops Q1 EPS by 2c; Updates FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
Piper Jaffray Raises Price Target on Johnson & Johnson (JNJ) Following 1Q Report
April 20, 2016 7:42 AM EDTPiper Jaffray reiterated a Neutral rating on Johnson & Johnson (NYSE: JNJ), and raised the price target to $106.00 (from $105.00), following the company's 1Q earnings report. In Pharma, total sales of $8.2B and key drug sales were slightly better than estimates. The Medical Device segment generated revenue of $6.11B,... More
